Record results mark 19th consecutive quarter of revenue growth
Q1 2008 Highlights:
- Product revenues increased 30% to a record $59.7 million
- Shipped 28,600 new pulse oximeters
- Rainbow revenues increased 104%
IRVINE, Calif., April 29, 2008 /PRNewswire-FirstCall/ -- Masimo Corporation (Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through-Motion-and-Low-Perfusion pulse oximetry, today announced its financial results for the 2008 first quarter ended March 29, 2008.
For the first quarter of 2008, Masimo reported product revenues of $59.7 million representing a 30% increase over $45.8 million for the first quarter of 2007. Including royalty revenues, Masimo reported total 2008 first quarter revenues of $71.1 million compared to $59.0 million for the first quarter of 2007. Net income for the 2008 first quarter was $8.8 million representing $0.15 per common share compared to $9.1 million or $0.11 per common share for the first quarter of 2007.
Masimo also reported that it shipped 28,600 Masimo SET and Masimo Rainbow SET oximetry units, excluding handheld units, during the first quarter of 2008. This represented an 8% increase from 26,500 units in the comparable prior year period, resulting in a new estimated net worldwide installed base of 491,000 Masimo SET pulse oximeters.
Joe E. Kiani, Chairman and Chief Executive Officer of Masimo, said, "We
are happy to report first quarter results that once again exceeded
expectations. We believe that these results reflect the increasing momentum
for the clinical adoption of our life saving Masimo SET and Masimo Rainbow
SET technologies. In fact, in the first quarter of 2
|SOURCE Masimo Corporation|
Copyright©2008 PR Newswire.
All rights reserved